Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving Growth Hubs in the Digital POCT Sector
Mobility ecosystem holds bold promise to expand patients’ access to care
Click image to view it in full size
World Health Organization (WHO) endorsed Point-of-Care Testing (POCT) as the topmost research priority in response to COVID-19 outbreak. Digital POCT platforms spurred the market demonstrating how the iterative nature of science can be leveraged to achieve The World Health Organization’s ASSURED criteria. POCT manufacturers are partnering with pharmaceutical drug developers leveraging new distribution channels to ensure rapid scalability of testing. The dawn of alternate care sites, 5G (cellular) with machine based intelligence, data analytics and IoT promises new ways to personalize diagnostic testing by reducing hospital visits, medical costs indicating a future driven by digitally empowered patient and connected diagnostic tests. The convergence is expected to pave the way for new macro-economic monetization models where consumers are empowered with dedicated network slices and edge storage in addition to artificial intelligence capabilities. While testing has already fired up in the retail sites, the connected-car ecosystem could offer multiple new revenue opportunities.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.
